Related Experiment Video
Updated: Jun 11, 2025

Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015
Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies
Merve Kulbay1, Kevin Y Wu2, Gurleen K Nirwal3
1Department of Ophthalmology & Visual Sciences, McGill University, Montreal, QC H4A 3S5, Canada.
Abstract:
This comprehensive review investigates the pivotal role of reactive oxygen species (ROS) in cataract formation and evaluates the potential of antioxidant therapies in mitigating this ocular condition. By elucidating the mechanisms of oxidative stress, the article examines how ROS contribute to the deterioration of lens proteins and lipids, leading to the characteristic aggregation, cross-linking, and light scattering observed in cataracts. The review provides a thorough assessment of various antioxidant strategies aimed at preventing and managing cataracts, such as dietary antioxidants (i.e., vitamins C and E, lutein, and zeaxanthin), as well as pharmacological agents with antioxidative properties. Furthermore, the article explores innovative therapeutic approaches, including gene therapy and nanotechnology-based delivery systems, designed to bolster antioxidant defenses in ocular tissues. Concluding with a critical analysis of current research, the review offers evidence-based recommendations for optimizing antioxidant therapies. The current literature on the use of antioxidant therapies to prevent cataract formation is sparse. There is a lack of evidence-based conclusions; further clinical studies are needed to endorse the use of antioxidant strategies in patients to prevent cataractogenesis. However, personalized treatment plans considering individual patient factors and disease stages can be applied. This article serves as a valuable resource, providing insights into the potential of antioxidants to alleviate the burden of cataracts.
Insights
Reactive oxygen species (ROS) drive cataract formation by damaging eye lens proteins. Antioxidant therapies show promise but require more clinical evidence for effective cataract prevention.
Area of Science:
- Ophthalmology
- Oxidative Stress Research
- Nutritional Science
Background:
- Reactive oxygen species (ROS) are implicated in the pathogenesis of cataracts, a leading cause of vision impairment.
- Oxidative stress induced by ROS leads to lens protein and lipid damage, causing aggregation and light scattering characteristic of cataracts.
Purpose of the Study:
- To comprehensively review the role of ROS in cataract development.
- To evaluate the efficacy of various antioxidant therapies for cataract prevention and management.
Main Methods:
- Literature review of studies on oxidative stress, ROS, and cataract formation.
- Assessment of dietary antioxidants (Vitamins C, E, lutein, zeaxanthin) and pharmacological agents.
- Exploration of novel therapeutic strategies like gene therapy and nanotechnology.
Main Results:
- ROS contribute to lens opacification through protein cross-linking and lipid peroxidation.
- Dietary and pharmacological antioxidants, alongside advanced delivery systems, are explored as potential interventions.
- Current evidence supporting antioxidant use for cataract prevention is limited, necessitating further clinical investigation.
Conclusions:
- While antioxidants show potential in mitigating oxidative stress in cataracts, robust clinical evidence is lacking.
- Further research, including clinical trials, is essential to validate antioxidant strategies for cataractogenesis prevention.
- Personalized treatment approaches considering individual patient factors are recommended.

